NCT05880030

Brief Summary

A group of runners received vitamin D (10,000 IU - international unit per day) for two weeks. The aim of the intervention was to check the effect of vitamin D supplementation on selected parameters of inflammation and iron metabolism in comparison with the placebo group. Blood was collected before and after supplementation. Next: before, after 25, 50, 75,100 km running and 12 hours after the run. The data were subjected to statistical analysis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 19, 2016

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 15, 2022

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
5 months until next milestone

First Posted

Study publicly available on registry

May 30, 2023

Completed
Last Updated

May 30, 2023

Status Verified

November 1, 2022

Enrollment Period

6 years

First QC Date

December 15, 2022

Last Update Submit

May 18, 2023

Conditions

Keywords

Vitamin DRunninginflammationserythropoietinironhepcidin

Outcome Measures

Primary Outcomes (6)

  • The change in vitamin 25(OH)D level after two-week supplementation.

    Measured parameter: vitamin 25(OH)D \[ng/ml\].

    Day 0 to day 14

  • The change in parathyroid hormone level after two-week supplementation.

    Measured parameter: parathyroid hormone \[pg/ml\].

    Day 0 to day 14

  • Observation of changes in inflammatory parameters:interleukin-6 induced by a 100 km run

    Measured parameter of inflammatory: interleukin-6 \[pg/ml\]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).

    Day "15 - the run" and day "16 - 12 hours after the run"

  • Observation of changes in inflammatory parameters: C reactive protein - CRP induced by 100 km running.

    Measured parameter of inflammatory: CRP\[mg/l\]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).

    Day "15 - the run" and day "16 - 12 hours after the run"

  • Observation of changes in creatine kinase level induced by 100 km running.

    Measured parameter: creatine kinase \[U/l\]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).

    Day "15 - the run" and day "16 - 12 hours after the run"

  • Observation of changes in leucocytes induced by 100 km running.

    Measured parameters of inflammatory: leukocytes \[G/l\]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).

    Day "15 - the run" and day "16 - 12 hours after the run"

Secondary Outcomes (8)

  • Observation of changes in hepcidin level induced by 100 km running.

    Day "15 - the run" and day "16 - 12 hours after the run"

  • Observation of changes in serum iron level induced by 100 km running.

    Day "15 - the run" and day "16 - 12 hours after the run"

  • Observation of changes in ferritin induced by 100 km running.

    Day "15 - the run" and day "16 - 12 hours after the run"

  • Observation of changes in erythrocytes level induced by a 100 km run.

    Day "15 - the run" and day "16 - 12 hours after the run"

  • Observation of changes in reticulocytes induced by a 100 km run.

    Day "15 - the run" and day "16 - 12 hours after the run"

  • +3 more secondary outcomes

Study Arms (2)

Vitamin D

ACTIVE COMPARATOR

Vigantol 10 000 IU/day (20 droplets) two weeks supplementation (vitamin D3)

Drug: Cholecalciferol

Control

PLACEBO COMPARATOR

sunflower oil, (20 droplets) two weeks supplementation.

Other: placebo

Interventions

cholecalciferol 10000 UI

Also known as: Vitamin D3
Vitamin D
placeboOTHER

sunflower oil

Control

Eligibility Criteria

Age28 Years - 64 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • male
  • athletes running ultra-marathons

You may not qualify if:

  • vitamin D3 supplementation
  • multivitamin and iron supplementation
  • serum 25(OH)D low \< 10 ng/mL
  • serum 25(OH)D high \> 100 ng/mL
  • haemoglobin \< 10 g/dL
  • other (sports injury, tournament)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myositis, Inclusion BodyInflammation

Interventions

Cholecalciferol

Condition Hierarchy (Ancestors)

MyositisMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Officials

  • Katarzyna Kasprowicz, PhD

    Gdansk University of Physical Education and Sport

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Both groups took drops from the same dark bottles, 20 drops per day for two weeks.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2022

First Posted

May 30, 2023

Study Start

October 19, 2016

Primary Completion

November 1, 2022

Study Completion

December 31, 2022

Last Updated

May 30, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share